Co-administration of temozolomide (TMZ) and the experimental therapeutic targeting miR-10b, profoundly affects the tumorigenic phenotype of human glioblastoma cells

Ming Chen(University of Washington), Anna Moore(Michigan State University)
Frontiers in Molecular Biosciences
June 15, 2023
Cited by 14


Related Papers